Ann Falsey
Bio
Dr Falsey is a Professor of Medicine at the University of Rochester School of Medicine. The focus of her research has been clinical and translational research in the field of respiratory viral infections in adults. Dr Falsey received her Doctorate in Medicine at Vanderbilt University School of Medicine. She completed her residency in Internal Medicine at Strong Memorial Hospital at the University of Rochester and Infectious Disease fellowship at Yale University and the University of Rochester. Initially, the focus of her research was defining the epidemiology and impact of respiratory syncytial virus (RSV) in adult populations. More recently, Dr Falsey has broadened her research to include numerous viral respiratory pathogens including influenza, coronaviruses, parainfluenza viruses and human metapneumovirus. She is presently the Co-PI of the University of Rochester, NIH sponsored clinical trial network, Vaccine Treatment and Evaluation Unit (VTEU). She has conducted numerous adult surveillance and vaccine studies in a variety of settings including nursing homes and senior daycare centers. A longstanding focus of her work has been the development of RSV vaccines for adult populations, and she participated in the early stages as well as the licensing vaccine trials for the recently approved RSV vaccines. When the COVID-19 pandemic hit in 2020, she and her colleagues immediately switched gears helped test and bring to market the COVID-19 vaccines. She continues to work on vaccine development and new methods of diagnosis for respiratory illnesses to improve human health.
Back to Speakers
